ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $60,000 | -16.7% | 16,737 | -41.2% | 0.00% | – |
Q4 2020 | $72,000 | +200.0% | 28,473 | +469.5% | 0.00% | – |
Q4 2019 | $24,000 | -45.5% | 5,000 | -50.0% | 0.00% | – |
Q1 2019 | $44,000 | +131.6% | 10,000 | 0.0% | 0.00% | – |
Q4 2018 | $19,000 | -40.6% | 10,000 | 0.0% | 0.00% | – |
Q3 2018 | $32,000 | -37.3% | 10,000 | -41.2% | 0.00% | – |
Q2 2018 | $51,000 | -23.9% | 17,000 | 0.0% | 0.00% | – |
Q1 2018 | $67,000 | -4.3% | 17,000 | 0.0% | 0.00% | – |
Q4 2017 | $70,000 | -32.7% | 17,000 | 0.0% | 0.00% | – |
Q3 2017 | $104,000 | -18.8% | 17,000 | +42.9% | 0.00% | -100.0% |
Q1 2015 | $128,000 | – | 11,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
SFMG, LLC | 62,433 | $334,000 | 0.07% |
Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |